Dr Will Dere on the ability to innovate | Amgen | Video

World Finance interviews Dr Will Dere, SVP and Chief Medical Officer at Amgen International, on their success and ability to innovate

May 10, 2010
Related Videos
  1. Fast and reliable execution is our priority, says Interstellar Group (FISG) director
  2. Grupo Financiero Banorte: Supporting Mexico for 125 years
Related:
  1. From passion purchase to portfolio strategy
  2. Background noise to boardroom threat
  3. Why Ireland rules Europe’s ETF market
  4. Debt diplomacy 2.0: Who owns emerging markets?
  5. The rise of the data state
  6. Financing Europe’s race for energy sovereignty
  7. America first, global health last?
  8. The dollar’s greatest threat is America itself
  9. Cybercrime emerges from the dark web
  10. The ‘AI-first’ CEO
Transcript

Dr Will Dere talks about his work investigating blood disorders, kidney disease and cancer; and the success Amgen has had with its product Prolia in treating ovarian cancer and healing fractures faster.